AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FONDAPARINUX SODIQUE
9 registrations across 2 African markets— 9 active
Markets with FONDAPARINUX SODIQUE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ARIXTRA 7.5 MG/0.6 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARIXTRA 2.5 MG/0.5 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARIXTRA seringue pre remplie / 2,5 mg / 0,5 ml | 🇸🇳Senegal | GLAXO SMITH KLINE | active | — |
| ARIXTRA 10 MG/0.8 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARIXTRA 5 MG/0.4 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARIXTRA 7.5 MG/0.6 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARIXTRA 10 MG/0.8 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARIXTRA 5 MG/0.4 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| ARIXTRA 2.5 MG/0.5 ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
FONDAPARINUX SODIQUE in Africa — Regulatory Overview
FONDAPARINUX SODIQUE is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.